Alpine Immune Sciences, Inc.'s board of directors voted to appoint Min Cui, Ph.D., Founder and Managing Director of Decheng Capital LLC (Decheng), as a director of the Company. Dr. Cui was appointed as a Class II director with a term expiring at the Company's 2020 annual meeting of stockholders. Dr. Cui was not appointed to any committees of the Board in connection with his initial appointment as a director. Dr. Cui was appointed to the Board in satisfaction of a condition to the Closing pursuant to the terms of the Purchase Agreement.